This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Acute Haemodynamic Impact of an IV Glucose-Injection

This study has been withdrawn prior to enrollment.
Information provided by:
University Hospital, Ghent Identifier:
First received: January 23, 2007
Last updated: April 9, 2009
Last verified: April 2009
Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Condition Intervention Phase
Peritoneal Dialysis Drug: Administration of an IV glucose-injection Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Acute Haemodynamic Impact of an IV Glucose-Injection

Resource links provided by NLM:

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Haemodynamic parameters
  • Glycemia

Estimated Enrollment: 20

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • > 18 years old
  • Stable clinical condition
  • Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion Criteria:

  • Heart Failure
  • Diabetes requiring insulin treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00426114

Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: Wim Van Biesen, University Hospital Ghent Identifier: NCT00426114     History of Changes
Other Study ID Numbers: 2007/016
Study First Received: January 23, 2007
Last Updated: April 9, 2009 processed this record on August 18, 2017